Skip to Content
Merck
CN

WG16

Wright-Giemsa Stain, Modified

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

UNSPSC Code:
41116121
eCl@ss:
42039003
NACRES:
NA.47
MDL number:
MFCD00132593

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

form

solution

shelf life

Expiry date on the label.

IVD

for in vitro diagnostic use

concentration

0.4 % (w/v) in methanol (buffered at pH 6.8)

pH

6.7-6.9

application(s)

hematology
histology

storage temp.

room temp

Quality Level

500

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

When blood films are stained using Wright-Giemsa Stain, the white blood cell nucleus and cytoplasm take on the characteristic blue or pink coloration. The combination of purified eosin and thiazine dyes in the product eliminates inconsistent staining and yields reproducible chromogenic responses.

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Eye Irrit. 2 - Flam. Liq. 2 - STOT SE 1

target_organs

Eyes,Central nervous system

Storage Class

3 - Flammable liquids

wgk

WGK 2

flash_point_f

51.8 °F - closed cup

flash_point_c

11 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Regulatory Information

监管及禁止进口产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000309639
0000309639
SLCR3064
SLCP8600
SLCN1143

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia
Jiang X, et al.
PLoS ONE, 8(8), e72335-e72335 (2013)
FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells
Liu F, et al.
Blood (2010)
Inhibition of CRL-NEDD8 pathway as a new approach to enhance ATRA-induced differentiation of acute promyelocytic leukemia cells
Liu S, et al.
International Journal of Medical Sciences, 15(7), 674-674 (2018)
Zhenfan Yang et al.
Science translational medicine, 8(368), 368ra172-368ra172 (2016-12-09)
Non-small-cell lung cancer patients with activating mutations in epidermal growth factor receptor (EGFR) respond to EGFR tyrosine kinase inhibitor (TKI) treatment. Nevertheless, patients often develop central nervous system (CNS) metastases during treatment, even when their extracranial tumors are still under
Mary P Lee et al.
Blood, 130(23), 2537-2547 (2017-10-12)
The orphan nuclear receptors TR4 (NR2C2) and TR2 (NR2C1) are the DNA-binding subunits of the macromolecular complex, direct repeat erythroid-definitive, which has been shown to repress
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service